Skip to content
10-Q/A

Quarterly Report

AVAI BIO, INC. AVAI

0001740797-25-000009

← back to feed
Filed
Jan 21, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Nov 12, 2024 131.87M sh
Operating Cash Flow Q2 2025 · Sep 30, 2024 −$838.76K
Operating Cash Flow Q2 2025 · Sep 30, 2023 −$480.13K
Short Term Debt Q2 2025 · Sep 30, 2024 $123.15K
Cash And Equivalents Q2 2025 · Sep 30, 2024 $1.77K
Cash And Equivalents Q2 2025 · Mar 31, 2024 $281
Stockholders Equity Q2 2025 · Sep 30, 2024 −$1.81M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$2.08M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$1.47M
Stockholders Equity Q2 2025 · Sep 30, 2023 −$991.3K
Stockholders Equity Q2 2025 · Jun 30, 2023 −$993.78K
Stockholders Equity Q2 2025 · Mar 31, 2023 −$633.26K
Current Liabilities Q2 2025 · Sep 30, 2024 $1.99M
Current Liabilities Q2 2025 · Mar 31, 2024 $1.79M
Total Liabilities Q2 2025 · Sep 30, 2024 $1.99M
Total Liabilities Q2 2025 · Mar 31, 2024 $1.79M
Current Assets Q2 2025 · Sep 30, 2024 $14.14K
Current Assets Q2 2025 · Mar 31, 2024 $116.08K
Total Assets Q2 2025 · Sep 30, 2024 $181.03K
Total Assets Q2 2025 · Mar 31, 2024 $322.01K
Eps Basic Q2 2025 · Sep 30, 2024 −$0.01
Eps Basic Q2 2025 · Sep 30, 2024 −$0.01
Eps Basic restated Q2 2025 · Sep 30, 2023 −$0.01
Eps Basic restated Q2 2025 · Sep 30, 2023 −$0.01
Sga Expense Q2 2025 · Sep 30, 2024 $422.84K
Sga Expense Q2 2025 · Sep 30, 2024 $677.51K
Sga Expense Q2 2025 · Sep 30, 2023 $371.97K
Sga Expense Q2 2025 · Sep 30, 2023 $733.46K
Net Income Q2 2025 · Sep 30, 2024 −$623.05K
Net Income Q2 2025 · Sep 30, 2024 −$1.15M
Net Income Q2 2025 · Jun 30, 2024 −$528.84K
Net Income Q2 2025 · Sep 30, 2023 −$399.62K
Net Income Q2 2025 · Sep 30, 2023 −$811.14K
Net Income Q2 2025 · Jun 30, 2023 −$411.52K